Vinita Singh¹, Nitin Kumar², Abhishek Bisai², Deborah Yukti Tandi¹, Harish Sharma¹ and Gyanesh Kumar Sahu¹

¹Rungta Institute of Pharmaceutical Sciences and Research, Kohka, Kurud, Bhilai, India ²Rungta Institute of Pharmaceutical Sciences, Kohka, Kurud, Bhilai, India

*Corresponding Author: Gyanesh Kumar Sahu, Dean and Professor, Rungta Institute of Pharmaceutical Sciences and Research, Kohka, Kurud, Bhilai, India.

Received: April 23, 2024; Published: April 30, 2024

Abstract

Dysmenorrhea, characterized by painful menstruation, poses a significant burden on women’s health and well-being. Diclofenac sodium, a potent nonsteroidal anti-inflammatory drug (NSAID), offers a promising approach for managing dysmenorrhea through its analgesic and anti-inflammatory properties. This abstract aims to evaluate the efficacy and safety of diclofenac sodium patches specifically in treating dysmenorrhea, drawing insights from available literature. Clinical trials and studies have demonstrated the effectiveness of diclofenac sodium patches in providing sustained pain relief and improving menstrual symptoms associated with dysmenorrhea. By delivering the drug transdermally, these patches offer targeted relief directly to the site of pain, bypassing gastrointestinal metabolism and potentially minimizing systemic adverse effects. Additionally, the convenience and ease of application make diclofenac sodium patches a favourable option for women seeking non-oral alternatives for managing menstrual pain. Despite the generally favourable safety profile observed in studies, careful monitoring is warranted to mitigate potential adverse effects, particularly skin irritation or allergic reactions. Overall, diclofenac sodium patches emerge as a promising and well-tolerated therapeutic option for effectively alleviating dysmenorrhea and enhancing the quality of life for women experiencing menstrual discomfort.

Keywords: Diclofenac Sodium; Dysmenorrhea; Non-Oral Alternatives

References

1. Goyal A., et al. “Potential of Novel Drug Delivery Systems for Herbal Drugs”. Indian Journal of Pharmaceutical Research and Education3 (2011): 225-235.
2. Archer HK and Pettit MS. “Analgesic and antichloristic compositions and therapeutic wrap for topical delivery” (1997).
3. Ghulaxe C and Verma R. “A review on transdermal drug delivery system”. The Pharma Innovation Journal1 (2015): 37-43.
4. Rathore B., et al. “Indian Herbal medicines: possible potent therapeutic agents for rheumatoid arthritis”. Journal of Clinical Biochemistry and Nutrition1 (2007): 12-17.
5. Park YG., et al. “A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5,dried extracts of six herbs, for the treatment of osteoarthritis of knee joint”. Journal of Ethnopharmacology3 (2013): 816-824.
6. Sahoo BJ and Mishra AN. “Formulation and evaluation of transdermal patches of diclofenac”. World Journal of Pharmacy and Pharmaceutical Sciences6 (2013): 4965-4971.
7. Gowda DV., et al. “Development and evaluation of Aceclofenac loaded transdermal film”. International Journal of Pharmtech Research4 (2010): 2224-2233.
8. Patel RP., et al. “Formulation and evaluation of transdermal patch of Aceclofenac”. International Journal of Drug Delivery 1: 41-51.
9. Gaikwad AK. “Transdermal drug delivery system: formulation aspects and evaluation”. Journal of Pharmaceutical Sciences 1 (2011): 1-10.
10. Santosh G., et al. “Formulation and evaluation of matrix type transdermal patches of Glibenclamide”. International Journal of Pharmaceutical Sciences and Drug Research1 (2009): 46-50.
11. Kumar SS., et al. “Formulation and evaluation of transdermal patch of Stavudine”. Journal of Pharmaceutical Sciences 1 (2013): 63-69.
12. Prabhakar P., et al. “Formulation development and Investigation of Domperidone transdermal patches”. International Journal of Pharm Investigation4 (2011): 240-246.
13. Jadhav RT., et al. “Formulation and evaluation of transdermal films of diclofenac sodium”. International Journal of PharmTech Research 4 (2009): 1507-1511.
14. Murthy SN., et al. “Formulation and evaluation of controlled release transdermal patches of theophylline-salbutamol sulphate”. Indian Journal of Pharmaceutical Education and Research2 (2001): 1057-1062.
15. Saxena M., et al. “Formulation and evaluation of transdermal patches of metoclopramide hydrochloride”. Indian Drugs9 (2006): 740-745.
16. Mali AD., et al. “An updated review on transdermal drug delivery systems”. International Journal of Advances in Scientific Research6 (2015): 244-254.
17. Darwhekar G., et al. “Formulation and evaluation of transdermal drug delivery system of Clopidogrelbisulfate”. Asian Journal of Pharmacy and Life Science3 (2011): 26.
18. Prajapati ST., et al. “Formulation and Evaluation of Transdermal Patch of repaglinide”. ISRN Pharma 2 (2011).

Citation

Citation: Gyanesh Kumar Sahu., et al. “Formulation and Evaluation of Diclophenac Sodium Transdermal Patches for Dysmenorrhea".Acta Scientific Pharmaceutical Sciences 8.6 (2024): 37-43.

Copyright

Copyright: © 2024 Gyanesh Kumar Sahu., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.